Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On December 11, 2019, upon the recommendation of the Nominating and Governance Committee, the Board of Directors (the "Board") of Methode Electronics, Inc. (the "Company") increased the size of the Board from eight to ten members. Upon the recommendation of the Nominating and Governance Committee, the Board elected David P. Blom and Angelo V. Pantaleo as directors of the Company to fill the vacancies. Messrs. Blom and Pantaleo will each serve as a director until their respective successor is elected and qualified or until his earlier resignation or removal. Upon the recommendation of the Nominating and Governance Committee, the Board appointed Mr. Blom to the Medical Products Committee and Mr. Pantaleo to the Technology Committee.
Mr. Blom, 65, served as President and Chief Executive Officer of OhioHealth Corporation, a not-for-profit healthcare system in Columbus, Ohio, from 2002 until his retirement on June 30, 2019. Mr. Blom serves as a director of Worthington Industries, Inc.
Mr. Pantaleo, 60, has served as Chairman and Chief Executive Officer of Marmon Holdings, Inc. (“Marmon”), a Berkshire Hathaway company and global industrial organization, since January 1, 2019 and as President of Marmon since December 1, 2017. Prior thereto, Mr. Pantaleo served as Chairman and Chief Executive Officer of Duracell, a Berkshire Hathaway company and leading manufacturer of alkaline batteries, since November 1, 2014.
Messrs. Blom and Pantaleo will be compensated in a manner consistent with the Company’s other non-employee directors, as most recently described in the Company’s Proxy Statement dated July 26, 2019.
A copy of the press release announcing the appointment of Messrs. Blom and Pantaleo to the Board is attached as Exhibit 99.1 to this Current Report on Form 8-K.